Funded Tech Companies
SciTech Development
Wondering who provided funding to SciTech Development? National Foundation for Cancer Research, Storm Lake Capital and HRN joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
SciTech Development
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2401 W. Belvedere Ave
Baltimore, MD 21215
USA
Baltimore, MD 21215
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
SciTech Development LLC was formed as a spin-off from the Karmanos Cancer Institute (KCI) and Wayne State University (WSU). As a recipient of a U.S. Small Business Innovation Research (SBIR) grant, SciTech's research focused on oncology drugs, specifically on fenretinide. Fenretinide had shown great promise as a cancer drug. However, fenretinide does not easily dissolve in the body, so it cannot get to cancer cells in high enough doses, which severely limited its effectiveness. The National Cancer Institute (NCI) issued a challenge to find a way to deliver fenretinide to cancer cells in greater concentrations, but without adverse or toxic side effects. SciTech subsequently received an SBIR grant from the NCI and successfully delivered on the promise of fenretinide. We developed and patented our first drug candidate ST-001 nanoFenretinide and proprietary SciTech Drug Delivery Platform (SDP).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/7/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Earle Holsapple
Chief Financial Officer
Andrew Stumpf
Chief Operating Officer
Louis Scarmoutzos
Chief Scientific Officer
Ralph Parchment
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs